Characterization of the genomic landscape in liver oligometastatic NSCLC

Characterization of the genomic landscape in liver oligometastatic NSCLC

Abstract Objectives Emerging data have shown that local treatment could provide clinical benefit for non-small cell lung cancer (NSCLC) patients with oligometastasis. Liver metastases have the worst prognosis in advanced NSCLC, but the genomic characteristics of liver oligometastasis remain unclear....

Full description

Saved in:

Bibliographic Details
Main Authors:	Rongxin Liao, Guangming Yi, Lu Shen, Xiao Xiao, Chuan Zeng, Liangzhong Liu, Hongjun Tang, Shunping Huang, Xiaoyue Zhang, Zaicheng Xu, Zhenzhou Yang, Yuan Peng
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	BMC Cancer
Subjects:	NSCLC Liver oligometastasis Genomic profiling Next-generation sequencing Tumor mutational burden
Online Access:	https://doi.org/10.1186/s12885-025-13478-5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
by: Lova Sun, MD, MSCE, et al.
Published: (2025-01-01)

Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
by: Mandy Jongbloed, MD, et al.
Published: (2025-03-01)

Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
by: Michael Ghadimi, et al.
Published: (2025-02-01)

Access to Diagnostics and Treatment for People With Metastatic EGFR-Positive NSCLC: Lessons From Project PRIORITY
by: Jill Feldman, MA, et al.
Published: (2025-03-01)

Clinical and genetic drivers of oligo-metastatic disease in colon cancer
by: Alessandro Ottaiano, et al.
Published: (2025-02-01)

Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
by: Arianna Marinello, MD, et al.
Published: (2025-03-01)

NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
by: Ismail M Meraz, et al.
Published: (2025-02-01)

Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience
by: Beatrice Manfredini, et al.
Published: (2025-01-01)

Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early-stage NSCLC
by: Domenico Lo Tartaro, et al.
Published: (2025-01-01)

Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator’s Consortium Registry Analysis
by: Margaret Stalker, MD, et al.
Published: (2025-01-01)

Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
by: Martina Ruglioni, et al.
Published: (2025-02-01)

CaGe: A Web-Based Cancer Gene Annotation System for Cancer Genomics
by: Young-Kyu Park, et al.
Published: (2012-03-01)

Negative experiences with primary care services in Norway expressed in patient and next-of-kin complaints – a qualitative study
by: Alison Axisa Eriksen, et al.
Published: (2025-01-01)

Differences in the genomic profiles of cell‐free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC
by: Zhen Wu, et al.
Published: (2019-03-01)

Case report: A case report and literature review on the efficacy of high-dose aumolertinib combined intrathecal pemetrexed by Ommaya reservoir for EGFR-mutated NSCLC with leptomeningeal metastasis as the initial symptoms
by: Maoxi Zhong, et al.
Published: (2025-01-01)

Outcomes of Pembrolizumab plus chemotherapy for patients with metastatic non-squamous NSCLC: Real-world evidence
by: Irina Surovtsova, et al.
Published: (2025-12-01)

Surgery for Patients With cT3/4N2M0, Stage IIIB NSCLC. Is It Time to Redefine Resectability?
by: J. Humberto Rodriguez-Quintero, MD, MPH, et al.
Published: (2025-01-01)

Decoding mutational signatures in breast cancer: Insights from a multi-cohort study
by: Margaux Betz, et al.
Published: (2025-03-01)

Association of tumour mutation burden with prognosis and its clinical significance in stage III gastric cancer
by: Ya-Lin Han, et al.
Published: (2024-11-01)

Genomic analysis of the SMN1 gene region in patients with clinically diagnosed spinal muscular atrophy: a retrospective observational study
by: Tamaki Kato, et al.
Published: (2025-02-01)

Low-exhaustion peripheral circulating γδ T cells serve as a biomarker for predicting the clinical benefit rate of non-small cell lung cancer (NSCLC) patients to chemotherapy or targeted therapy: a single-center retrospective study
by: Dongdong Zhang, et al.
Published: (2025-01-01)

Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience
by: Ezgi Genç Erdoğan, et al.
Published: (2023-07-01)

Comparative safety profile of tyrosine kinase inhibitors in NSCLC: a network meta-analysis of hypertension and thrombotic risks
by: Mingming Tan, et al.
Published: (2025-01-01)

BRAF V600E-mutated lung adenocarcinoma with thyroid metastasis as the initial manifestation: a case report
by: Yufei Liu, et al.
Published: (2025-02-01)

A rare case of vision loss caused by leptomeningeal metastasis of lung adenocarcinoma: a case report and literature review
by: Zhihua Li, et al.
Published: (2025-02-01)

Pembrolizumab with external radiation therapy effectively controlled TMB-high unresectable recurrent parathyroid cancer: a case report with review of literature
by: Hiroshi Katoh, et al.
Published: (2024-11-01)

Characterization of a WAS splice-site variant in a patient with Wiskott-Aldrich syndrome
by: Elisabetta Toriello, et al.
Published: (2025-01-01)

Circulating Tumor DNA Detection for Recurrence Monitoring of Stage I Non‐Small Cell Lung Cancer Treated With Microwave Ablation
by: Lin Cheng, et al.
Published: (2025-01-01)

Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada
by: Lara Chayab, et al.
Published: (2024-12-01)

Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC
by: Helena Bote-de Cabo, MD, et al.
Published: (2025-03-01)

Integrative prognostic modeling of ovarian cancer: incorporating genetic, clinical, and immunological markers
by: Aidi Lin, et al.
Published: (2025-02-01)

MAP: Mutation Arranger for Defining Phenotype-Related Single-Nucleotide Variant
by: In-Pyo Baek, et al.
Published: (2014-12-01)

IL-17 triggers PD-L1 gene transcription in NSCLC cells via TRIM31-dependent MEF2C K63-linked polyubiquitination
by: Shuai Ying, et al.
Published: (2025-01-01)

Re-evaluating evidence for giant genomes in amoebae
by: Daniel Barzilay, et al.
Published: (2024-12-01)

CTSG is a prognostic marker involved in immune infiltration and inhibits tumor progression though the MAPK signaling pathway in non-small cell lung cancer
by: Qian Dai, et al.
Published: (2024-12-01)

Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy
by: Yuanshan Yao, et al.
Published: (2025-02-01)

Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway
by: Wang Naizhi, et al.
Published: (2020-09-01)

Genome sequencing enhances the diagnostic yield and expands the genetic landscape of male breast cancer
by: Wen Wen, et al.
Published: (2025-01-01)

Perspectives of Integrative Cancer Genomics in Next Generation Sequencing Era
by: So Mee Kwon, et al.
Published: (2012-06-01)

Population Genomics Reveals Elevated Inbreeding and Accumulation of Deleterious Mutations in White Raccoon Dogs
by: Yinping Tian, et al.
Published: (2025-01-01)